Kevin G. McLure
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Cancer-related Molecular Pathways, Multiple Myeloma Research and Treatments, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin(2005)660 cited
- → DNA-dependent protein kinase acts upstream of p53 in response to DNA damage(1998)309 cited
- → How p53 binds DNA as a tetramer(1998)256 cited
- → BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma(2014)219 cited
- → RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist(2013)198 cited
- → Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of Dimers(2002)133 cited
- → A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice(2014)130 cited
- → NAD+ Modulates p53 DNA Binding Specificity and Function(2004)86 cited
- → BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells(2016)57 cited
- → RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease(2017)56 cited